Medifast Chief Legal Officer Resigns Amidst Ongoing Leadership Changes
MED sits 43% above its 52-week low of $9.22 on elevated volume (1.9× avg).
Summary
Jason L. Groves has resigned as Medifast's Chief Legal Officer and Corporate Secretary, effective May 29, 2026, receiving a one-month severance payment. This departure follows a period of significant corporate upheaval, including an activist investor agreement in March and a CEO transition finalized just days prior on May 26. While the company stated the resignation was not due to disagreement, the exit of a key legal executive adds to the leadership instability as the small-cap company navigates financial challenges and restructuring.
At the time of this announcement, MED was trading at $13.19 on NYSE in the Trade & Services sector, with a market capitalization of approximately $139.3M. The 52-week trading range was $9.22 to $15.46. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.